SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Drugs >

Elite Pharmaceuticals (ELTP)

ELTP RSS Feed
Add ELTP Price Alert      Hide Sticky   Hide Intro
Moderator: Mocha Jet, Drugdoctor, joseytheoutlawwales, lasers, NASDAQ2020, IB_
Search This Board: 
Last Post: 8/21/2017 6:52:11 AM - Followers: 834 - Board type: Free - Posts Today: 3

Elite Pharmaceuticals, Inc. (ELTP)

 
About Elite Pharmaceuticals
 
Elite Pharmaceuticals is a specialty pharmaceutical company specializing in niche generics and committed to the development of abuse-deterrent opioids to help curb diversion, misuse and abuse.  Elite has a pipeline of opioid abuse-deterrent products under development utilizing the company’s proprietary pharmacological abuse-deterrent technology. 
 
Located in Northvale, New Jersey, Elite operates a 55,000 square foot campus under Current Good Manufacturing Practice (“cGMP”) and is a United States Drug Enforcement Agency (“DEA”) registered facility for research, development, manufacturing and packaging of pharmaceutical products.
 
More information including Elite’s proprietary Abuse Resistant Technology can be found at http://www.elitepharma.com
 


About Elite's Abuse Deterrent Technology

Elite's abuse deterrent products utilize the Company's proprietary pharmacological abuse deterrent technology. Elite's abuse deterrent technology is a multi-particulate capsule which contains an opioid agonist in addition to naltrexone, an opioid antagonist. Naltrexone is an opioid receptor antagonist used primarily in the management of alcohol dependence and opioid dependence. When this product is taken as intended, the naltrexone is designed to pass through the body unreleased while the opioid agonist releases over time providing therapeutic pain relief for which it is prescribed. If the multi-particulate beads are crushed, the opioid antagonist, naltrexone, is designed to release. The absorption of the naltrexone is intended to block the euphoria by preferentially binding to same receptors in the brain as the opioid agonist and thereby reducing the incentive for abuse or misuse by recreational drug abusers.
 
Elite continues to expands the intellectual property for the Company's opioid abuse deterrent technology. Elite now has four US patents, one European patent, and two Canadian patents issued in this area with additional patents pending in the U.S., Canada and Europe.
 
Products & Pipeline
 
Screen%20Shot%202017-05-28%20at%2011.53.29%20AM.png
 
Elite’s principle product is SequestOx, an immediate-release oxycodone with sequestered naltrexone abuse-deterrent opioid product for the management of moderate to severe acute pain. Additional products include bariatric, cardiovascular, antihistamine, skeletal muscle relaxants, antipsychotic, tricyclic antidepressant, along with a number of approved products pending manufacturing site transfer.
 
Elite owns generic and OTC products which have been licensed to TAGI Pharma, Epic Pharma, Dr. Reddy's Laboratories and Valeant Pharmaceuticals International. Additional information regarding Elite’s wholly owned products, partnerships, and contract manufacturing can be found at  http://www.elitepharma.com/products
 
The list of pipeline products can be found at http://www.elitepharma.com/pipeline-generics
 
Leadership
 
Nasrat Hakim, Chairman, President & Chief Executive Officer
 
Nasrat Hakim joined Elite in August 2013 as Director, President and Chief Executive Officer. Mr. Hakim has more than 30 years of pharmaceutical and medical industry experience in Quality Assurance, Analytical Research and Development, Technical Services and Regulatory Compliance. He brings with him proven management experience, in-depth knowledge of manufacturing systems, development knowledge in immediate and extended release formulations and extensive regulatory experience of GMP and FDA regulations. Prior to his leading Elite, from 2004 to 2013, Mr. Hakim was employed by Actavis, Watson and Alpharma in various senior management positions. Most recently, Mr. Hakim served as International Vice President of Quality Assurance at Actavis, overseeing 25 sites with more than 3,000 employees under his leadership.  Mr. Hakim also served as Corporate Vice President of Technical Services, Quality and Regulatory Compliance for Actavis U.S., Global Vice President, Quality and Regulatory Compliance for Alpharma, as well as Executive Director of Quality Unit at TheraTech, overseeing manufacturing and research and development. In 2009, Mr. Hakim founded Mikah Pharma, LLC, a virtual, fully functional pharmaceutical company. 

Mr. Hakim’s career started in Medical Laboratory Technology from the Academy of Health and Sciences in the U.S. Army based in San Antonio, TX, followed by Graduate Certification in Regulatory Affairs (RAC) from California State University at Sacramento, Sacramento, CA; Bachelor in Chemistry/Bio-Chemistry and Masters of Science in Chemistry from California State University at Sacramento, Sacramento, CA; and a Masters in Law with Graduate Certification in U.S. Taxation from St. Thomas University, School of Law, Miami, FL.
 

Investor Relations and Corporate Inquiries

Dianne Will
Vice President of Investor Relations and Corporate Affairs
Telephone: 518-398-6222
Email: 
dianne@elitepharma.com

Corporate Headquarters
165 Ludlow Avenue
Northvale, New Jersey 07647
Phone: 201-750-2646
Fax: 201-750-2755


 

Miscellaneous Links:
 
Elite Pharmaceuticals News
http://ir.elitepharma.com/press_releases
 
SEC Filings
http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001053369&owner=include

FDA website
http://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.DrugDetails

Clinical Trials.Gov
https://www.clinicaltrials.gov/
 
Yahoo Finance
https://finance.yahoo.com/quote/ELTP/?p=ELTP
 
Seeking Alpha
https://seekingalpha.com/symbol/ELTP
 

ELTP Daily Chart
    


ELTP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ELTP News: Current Report Filing (8-k) 08/09/2017 05:01:18 PM
ELTP News: Quarterly Report (10-q) 08/09/2017 04:30:20 PM
ELTP News: Current Report Filing (8-k) 07/28/2017 12:59:52 PM
ELTP News: Confidential Treatment Order (ct Order) 07/12/2017 05:00:02 PM
ELTP News: Current Report Filing (8-k) 07/12/2017 04:02:10 PM
PostSubject
#268030  Sticky Note My prediction is the FDA will say benefits outweigh Bngo 08/03/17 07:01:11 AM
#260714  Sticky Note Uh, no. WeeZuhl 06/13/17 02:21:47 PM
#247416  Sticky Note HERE is WHAT long term investors need to UNDERSTAND!!! Couch 03/21/17 06:12:24 PM
#234937  Sticky Note THIS IS WHAT YOU NEED TO KNOW BEFORE Couch 11/30/16 03:04:07 PM
#189564  Sticky Note $ELTP SequestOx and ADF Patents lasers 03/18/16 04:29:26 AM
#185967  Sticky Note The only topic here is ELTP. IH Admin [Dan] 02/23/16 09:32:46 PM
#17570   Tell, if it means nothing why do so richme 05/24/12 10:43:57 PM
#17569   Yes where is the revenue? You did richme 05/24/12 10:42:39 PM
#17568   You didn't answer the question tangerine 05/24/12 10:36:30 PM
#17567   I have no knowledge of those companies and packerfanbud 05/24/12 10:34:27 PM
#17566   Tangerine, a perfect example of what I just richme 05/24/12 10:32:31 PM
#17563   It would not change my mind at all. richme 05/24/12 10:26:18 PM
#17562   poorme, Since you are so hung up on packerfanbud 05/24/12 10:10:47 PM
#17561   How long do you think we have to elichen 05/24/12 10:00:25 PM
#17560   Poorme reading what you (LOL) just wrote it tangerine 05/24/12 09:52:38 PM
#17557   What part of the list do have issue AbbottRD 05/24/12 08:39:00 PM
#17556   The problem with the list that gets posted dr_lowenstein 05/24/12 07:29:39 PM
#17554   Poorme, I am not sure what your time AbbottRD 05/24/12 07:05:35 PM
#17553   for a huge dud i sure made some ev3ryth1ng t4k3n 05/24/12 07:03:03 PM
#17552   I am walking the Elite talk. I bot lasers 05/24/12 06:37:01 PM
#17550   How positive are you that this won't be richme 05/24/12 06:07:29 PM
#17549   Absolutely:) Agree 100% on ELTP pm RizZo 05/24/12 04:40:04 PM
#17548   Added more big time! In 35 days the lasers 05/24/12 04:37:43 PM
#17547   Great GREEN close folks... Nice ask slaps... Good Drugdoctor 05/24/12 04:02:45 PM
#17546   Dr. L. Don't you believe that is possible? richme 05/24/12 03:52:49 PM
#17545   Wow a million shares traded and not a dr_lowenstein 05/24/12 03:34:08 PM
#17544   No one is selling. Just games. Seems people tangerine 05/24/12 03:30:15 PM
#17543   Those .13's are looking very tempting here! lasers 05/24/12 03:27:36 PM
#17542   Those .13's are looking very tempting here! Drugdoctor 05/24/12 03:23:49 PM
#17541   The patent was worthless there for a second tangerine 05/24/12 02:56:47 PM
#17540   Got it. Thanks! TRaine 05/24/12 02:55:47 PM
#17539   IMO yes. I added more. lasers 05/24/12 02:47:24 PM
#17538   It is pretty big. But consolidation here would conix 05/24/12 02:41:51 PM
#17537   so the overhang isn't as daunting given the packerfanbud 05/24/12 02:39:46 PM
#17536   The longer it has been and the lower conix 05/24/12 02:33:10 PM
#17535   if the buying had been done last week packerfanbud 05/24/12 02:27:43 PM
#17534   So what is the next play now as TRaine 05/24/12 02:27:08 PM
#17533   It can tell how much you have to conix 05/24/12 02:23:31 PM
#17532   what does the overhang at .18 tell us? packerfanbud 05/24/12 02:19:32 PM
#17531   Money Flow Chart conix 05/24/12 02:13:50 PM
#17530   Flippers look to be gone, hope we can DR Ryan 05/24/12 12:57:19 PM
#17529   15% of the profit for each product. I tangerine 05/24/12 12:20:51 PM
#17528   You haven't answered my question either. Where richme 05/24/12 12:14:23 PM
#17527   So why did you ask? richme 05/24/12 12:12:46 PM
#17526   So you have been trading this stock and Drugdoctor 05/24/12 12:11:02 PM
#17525   Wrong, you haven't sold yet. Maybe wait until tangerine 05/24/12 12:10:52 PM
#17524   As I leave... NITE just parked at .15, Drugdoctor 05/24/12 12:08:47 PM
#17523   Close to $16K at this point. richme 05/24/12 12:08:36 PM
#17522   Return to normal trading... I've been watching level Drugdoctor 05/24/12 12:05:55 PM
#17521   How much have you lost? Drugdoctor 05/24/12 11:46:03 AM
#17520   Thanks; I do understand that staying long has richme 05/24/12 11:20:03 AM
#17519   Poorme...I think you're on the right track atomicdogs 05/24/12 11:10:28 AM
#17518   New product Launch NEWS expected at any time! Drugdoctor 05/24/12 10:47:24 AM
#17517   I am with etrade and have been on rdragon 05/24/12 10:28:20 AM
#17516   If shorts are trying to cover now, they Drugdoctor 05/24/12 10:15:59 AM
#17515   We told everyone why the price was going Drugdoctor 05/24/12 10:14:22 AM
PostSubject